Biocryst Pharmaceuticals
Earnings Surprise
Analysts estimated BCRX earnings of $0.04 per share this quarter (Q4). BCRX's actual earnings were $0.01 per share.
BCRX EPS surprise of 286.00%Analysts estimated BCRX earnings of $0.04 per share this quarter (Q3). BCRX's actual earnings were $0.06 per share.
BCRX EPS surprise of 67.13%Analysts estimated BCRX earnings of $0.01 per share this quarter (Q2). BCRX's actual earnings were $0.04 per share.
BCRX EPS surprise of 179.72%Analysts estimated BCRX earnings of $-0.06 per share this quarter (Q4). BCRX's actual earnings were $-0.13 per share.
BCRX EPS surprise of -123.75%Analysts estimated BCRX earnings of $-0.07 per share this quarter (Q3). BCRX's actual earnings were $-0.07 per share.
BCRX EPS surprise of -6.54%Analysts estimated BCRX earnings of $-0.18 per share this quarter (Q2). BCRX's actual earnings were $-0.06 per share.
BCRX EPS surprise of 66.24%Analysts estimated BCRX earnings of $-0.22 per share this quarter (Q1). BCRX's actual earnings were $-0.17 per share.
BCRX EPS surprise of 20.97%Analysts estimated BCRX earnings of $-0.25 per share this quarter (Q4). BCRX's actual earnings were $-0.28 per share.
BCRX EPS surprise of 12.49%